Pesquisar
Repare Therapeutics Inc
RPTXAdicionar à lista de desejos
2.650USD
0.0000.00%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
114.24MValor de mercado
PerdaP/L TTM
Mais detalhes de Repare Therapeutics Inc Empresa
Repare Therapeutics Inc. is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its pipeline includes RP-3467, a Phase 1 Polo ATPase inhibitor; RP-1664, a Phase 1 PLK4 inhibitor, and lunresertib, a PKMYT1 inhibitor.
Informações de Repare Therapeutics Inc
Código da empresaRPTX
Nome da EmpresaRepare Therapeutics Inc
Data de listagemJun 19, 2020
CEOForte (Steve)
Número de funcionários129
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 19
Endereço7210 Frederick-Banting, Suite 100
CidadeST-LAURENT
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísCanada
Código postalH4S 2A1
Telefone18574127018
Sitehttps://www.reparerx.com/
Código da empresaRPTX
Data de listagemJun 19, 2020
CEOForte (Steve)
Executivos da empresa Repare Therapeutics Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Michael Zinda, Ph.D.
Dr. Michael Zinda, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
48.78K
--
Mr. Steve Forte
Mr. Steve Forte
President, Chief Executive Officer, Chief Financial Officer, Director
President, Chief Executive Officer, Chief Financial Officer, Director
25.28K
--
Ms. Sandra Alves
Ms. Sandra Alves
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
12.82K
-146.62%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
--
-100.00%
Dr. David P. Bonita, M.D.
Dr. David P. Bonita, M.D.
Independent Director
Independent Director
--
--
Dr. Samarth Kulkarni, Ph.D.
Dr. Samarth Kulkarni, Ph.D.
Independent Director
Independent Director
--
--
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
--
-100.00%
Mr. Thomas Civik
Mr. Thomas Civik
Independent Chairman of the Board
Independent Chairman of the Board
--
-100.00%
Dr. Susan M. Molineaux, Ph.D.
Dr. Susan M. Molineaux, Ph.D.
Independent Director
Independent Director
--
--
Dr. Steven H. Stein, M.D.
Dr. Steven H. Stein, M.D.
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Michael Zinda, Ph.D.
Dr. Michael Zinda, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
48.78K
--
Mr. Steve Forte
Mr. Steve Forte
President, Chief Executive Officer, Chief Financial Officer, Director
President, Chief Executive Officer, Chief Financial Officer, Director
25.28K
--
Ms. Sandra Alves
Ms. Sandra Alves
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
12.82K
-146.62%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
--
-100.00%
Dr. David P. Bonita, M.D.
Dr. David P. Bonita, M.D.
Independent Director
Independent Director
--
--
Dr. Samarth Kulkarni, Ph.D.
Dr. Samarth Kulkarni, Ph.D.
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Repare Therapeutics Inc?
Os cinco principais acionistas de Repare Therapeutics Inc são: Dr. Michael Zinda, Ph.D.
Quantas instituições possuem ações da Repare Therapeutics Inc (RPTX)?
Em 2025Q4, 116 instituições possuíam ações da Repare Therapeutics Inc, com valor de mercado aproximado de 24.72M, representando 57.35% do total de ações. Em comparação com 2025Q3, a participação institucional aumentou em -9601917.00.